We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
+16.12%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$17.3B
AUM Growth
+$6.88B
(+66%)
Cap. Flow
+$6.5B
Cap. Flow
% of AUM
37.62%
Top 10 Holdings %
Top 10 Hldgs %
46.83%
Holding
2,057
New
934
Increased
622
Reduced
249
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Large Cap Deep Quarterly Laddered ETF
IVVB
|
+$1.81B |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$893M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$111M |
| 5 |
Amazon
AMZN
|
+$89.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$189M |
| 2 |
NVIDIA
NVDA
|
+$73.1M |
| 3 |
Pfizer
PFE
|
+$48.6M |
| 4 |
Blackrock
BLK
|
+$41.2M |
| 5 |
Apple
AAPL
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.5% |
| 2 | Financials | 6.1% |
| 3 | Industrials | 4.6% |
| 4 | Consumer Discretionary | 3.96% |
| 5 | Communication Services | 3.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UNIT
1751
Uniti Group
UNIT
$2.32B
| $148K | ﹤0.01% |
34,254
+19,346
| +130% | +$86.9K |
|
1752
Achieve Life Sciences
ACHV
$683M
| $145K | ﹤0.01% |
+64,348
| New | +$183K |
|
1753
Carlyle Secured Lending
CGBD
$758M
| $145K | ﹤0.01% |
+10,592
| New | +$151K |
|
1754
Cullinan Oncology
CGEM
$1.14B
| $145K | ﹤0.01% |
19,227
-21,372
| -53% | -$172K |
|
1755
Dyne Therapeutics
DYN
$4.9B
| $144K | ﹤0.01% |
+15,123
| New | +$166K |
|
|
HDSN
1756
Hudson Technologies
HDSN
$235M
| $139K | ﹤0.01% |
+17,159
| New | +$118K |
|
1757
Kosmos Energy
KOS
$1.48B
| $139K | ﹤0.01% |
80,576
-18,067
| -18% | -$32.7K |
|
1758
Repay Holdings
RPAY
$327M
| $137K | ﹤0.01% |
+28,369
| New | +$130K |
|
1759
Gold Royalty Corp
GROY
$699M
| $136K | ﹤0.01% |
+61,679
| New | +$108K |
|
1760
Quad
QUAD
$525M
| $135K | ﹤0.01% |
+23,838
| New | +$129K |
|
1761
Zymeworks
ZYME
$1.67B
| $133K | ﹤0.01% |
+10,628
| New | +$127K |
|
1762
Atea Pharmaceuticals
AVIR
$420M
| $132K | ﹤0.01% |
+36,567
| New | +$109K |
|
1763
Annexon
ANNX
$886M
| $128K | ﹤0.01% |
53,283
-8,791
| -14% | -$17.6K |
|
|
HOUS
1764
DELISTED
Anywhere Real Estate
HOUS
| $126K | ﹤0.01% |
+34,701
| New | +$121K |
|
|
AGNT
1765
AGNT Inc
AGNT
$734M
| $123K | ﹤0.01% |
+13,551
| New | +$118K |
|
1766
Under Armour
UAA
$2.6B
| $120K | ﹤0.01% |
17,639
-129,901
| -88% | -$809K |
|
|
SRTA
1767
Strata Critical Medical Inc
SRTA
$512M
| $120K | ﹤0.01% |
+29,877
| New | +$97.2K |
|
1768
Emergent Biosolutions
EBS
$248M
| $119K | ﹤0.01% |
18,724
+5,743
| +44% | +$32.9K |
|
1769
Heartland Express
HTLD
$956M
| $118K | ﹤0.01% |
+13,675
| New | +$117K |
|
|
KW
1770
DELISTED
Kennedy-Wilson Holdings
KW
| $116K | ﹤0.01% |
+17,130
| New | +$114K |
|
1771
AlTi Global
ALTI
$493M
| $114K | ﹤0.01% |
27,600
+1,316
| +5% | +$4.54K |
|
1772
Payoneer
PAYO
$2.41B
| $110K | ﹤0.01% |
+16,130
| New | +$109K |
|
1773
Rackspace Technology
RXT
$1.24B
| $109K | ﹤0.01% |
85,472
+32,996
| +63% | +$43K |
|
1774
Kearny Financial
KRNY
$599M
| $106K | ﹤0.01% |
+16,358
| New | +$101K |
|
|
AIV
1775
Aimco
AIV
$383M
| $103K | ﹤0.01% |
11,892
-4,071
| -26% | -$32.9K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
GIM
DWM
MIFH
Brevan Howard Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Brevan Howard Capital Management held 2,057 positions worth $17.3B, up 66% from $10.4B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Brevan Howard Capital Management deployed $6.5B of net new capital in Q2 2025, opening 934 new positions and adding to 622 existing holdings. Its largest new stake was iShares Large Cap Deep Quarterly Laddered ETF: 60,706,457 shares worth $461M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 4.6% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was NVIDIA, an estimated $73.1M trimmed.
- Brevan Howard Capital Management's largest Q2 2025 buy was iShares Large Cap Deep Quarterly Laddered ETF: 60,706,457 shares worth $461M.
- Brevan Howard Capital Management added most to iShares Bitcoin Trust in Q2 2025, an estimated $893M increase.
- Brevan Howard Capital Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $73.1M.
- Brevan Howard Capital Management fully exited iShares MSCI Emerging Markets ETF in Q2 2025, selling an estimated $189M.
- Brevan Howard Capital Management's ten largest holdings make up 47% of its $17.3B portfolio in Q2 2025.
- Brevan Howard Capital Management opened 934 new positions and closed 240 in Q2 2025.
- Brevan Howard Capital Management's portfolio value rose 66% quarter-over-quarter to $17.3B.
Based on Brevan Howard Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.